Research partnership aims to apply MS technology to life science research.
Northeastern University’s Barnett Institute of Chemical and Biological Analysis (USA) recently announced a new collaboration with Thermo Fisher Scientific. The partnership will focus on the application of MS technology to life science research, specifically three main areas: complex protein characterization, development of new methods for analyzing trace amounts of biomarkers in proteomic samples and methods for analyzing biosimilar drugs.
Researchers joined together for the recent announcement; a discussion of the partnership’s expected impact, and a tour of the Barnett laboratory also took place. Barry Karger, Director of the Institute and Ian Jardine, Vice President and Chief Technology Officer at Thermo Fisher, presented their research highlights from previous years and also ideas for future investigations. Jardine stated, “We’re only at the beginning of this journey in the application of MS to life sciences.”
This is not the first time that the two institutions have worked together. In 1998, to celebrate the Barnett Institute’s 25th anniversary, Northeastern and Thermo Fisher set up a young scholars program aimed at establishing the careers of analytical chemists.
Murray Gibson, Dean of the College of Science, where the Barnett Institute is based, discussed the partnership, “Building on relationships with instrument and biotech companies is a way not only to provide opportunities for coop and training, but also to bring to us the state-of-the-art technology that allows us to do the most exciting science.”
Dan Shine, President of the chromatography and MS division at Thermo Fisher stated, “This is a tremendous partnership, and we’re honored to be working closely with a leading institute like Northeastern. These relationships are really important to helping us understand the requirements of leading academics and helping us improve the instrumentation we make, improve our software, and improve our applications knowledge.”
Karger explained the importance of future research collaborations between academia, government and industry, “We think this is critical, because nobody has all the answers.”